| # | Drug | Count |
|---|---|---|
| 0 | DACARBAZINE | 5 |
| 1 | RITUXIMAB | 5 |
| 2 | CYCLOPHOSPHAMIDE | 4 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 5 | DOXORUBICIN | 4 |
| 6 | RITUXIMAB-ABBS | 4 |
| 7 | ADALIMUMAB-ADAZ | 3 |
| 8 | DOXORUBICIN HYDROCHLORIDE | 3 |
| 9 | LENALIDOMIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CODEINE PHOSPHATE AND GUAIFENESIN | 1 | 0.0093 |
| 1 | VINBLASTINE SULFATE | 2 | 0.0010 |
| 2 | RITUXIMAB-ABBS | 4 | 0.0008 |
| 3 | DACARBAZINE | 5 | 0.0007 |
| 4 | RALTEGRAVIR | 2 | 0.0004 |
| 5 | GARLIC | 1 | 0.0002 |
| 6 | BLEOMYCIN SULFATE | 2 | 0.0002 |
| 7 | BRENTUXIMAB VEDOTIN | 2 | 0.0002 |
| 8 | CANAKINUMAB | 2 | 0.0002 |
| 9 | VINORELBINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 1 | Alkylating Drug [EPC] | 7 | 0.0000 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 9 | 0.0000 |
| 3 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 5 | Non-Standardized Food Allergenic Extract [EPC] | 1 | 0.0000 |
| 6 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |